Document is current
Any future updates will be listed below
-
Authors
Tsahouridis, Ourania https://orcid.org/0000-0003-0621-6753
Xu, Max
Song, Feifei https://orcid.org/0000-0002-8866-1270
Savoldo, Barbara
Dotti, Gianpietro https://orcid.org/0000-0002-2639-8526
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA243543, R01-CA256898, R01-CA247436, R01-CA247497)
- License Information
-
More Information
Article History
Received: 13 October 2024
Accepted: 29 May 2025
First Online: 18 July 2025
Competing interests
: G.D. serves on the SAB of NanoCell, Estella, Arovella and Outpace Bio. G.D. is a cofounder of Persistence Bio. G.D and B.S. hold patents in the field of CAR-engineered cells. The other authors declare no competing interests.
